When does this change take effect?

This change is effective Jul 1, 2025.

Medicare AdvantageCoverageMedium impact

MA08.004y, Coagulation Factors

Q: Who is affected by this change?

This affects Independence Blue Cross Hematology, Oncology, Emergency Medicine, Critical Care providers on Medicare Advantage plans.

Independence Blue Cross·Hematology, Oncology, Emergency Medicine +1 more·Medical Policy

Effective date

Jul 1, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Medicare Advantage policy MA08.004y regarding Coagulation Factors has been updated with an effective date of July 1, 2025. This is a fresh policy change that may affect billing procedures, coverage criteria, or prior authorization requirements for coagulation factor treatments.

Action Required

Action needed

By July 1, 2025: Billing team must review the full MA08.004y Coagulation Factors policy at the provided URL to identify specific changes to billing procedures, prior authorization requirements, or coverage criteria. Update billing system and staff protocols accordingly for all Medicare Advantage plans.

Related policy hubs

Independence Blue Cross policies Hematology Oncology Emergency Medicine Critical Care